Senior Investigator Profile

TitleProfessor
First NameDavid
SurnameDearnaley
Award StatusEmeritus
Current PostProfessor of Uro-Oncology and Honorary Consultant Clinical Oncologist
DepartmentUrology
Telephone020 8661 3271
EmailDavid.Dearnaley@rmh.nhs.uk
InstitutionRoyal Marsden Hospital and Institute of Cancer Research
NHS TrustThe Royal Marsden NHS Foundation Trust
Region NameLondon
Primary Research FieldNephrology & Urology
Secondary Research FieldNephrology & Urology
BiographyDavid Dearnaley has been Professor of Uro-Oncology at the Institute of Cancer Research (ICR) and Royal Marsden Hospital (RMH) since 2003. He is currently Chairman of the RMH/ICR Committee for Clinical Research and Prostate Cancer Theme Lead for the RMH/ICR NIHR Biomedical Research Centre. He was appointed NIHR Senior Investigator in 2008/2012 and has previously chaired the MRC and NCRI Prostate and Radiotherapy Study Groups. Principal areas of research are in the development of conformal, dose escalated and, subsequently, intensity modulated (IMRT) and image guided (IGRT) radiotherapy treatments for prostate cancer. He has led phase III randomised trials to establish these in clinical practice with subsequent inclusion in NICE guidance. He is Chief Investigator leading a multicentre trial of IMRT using hypofractionated schedules; known as CHHiP this is the largest academic treatment trial completed in prostate cancer. He leads translational research projects using novel biomarkers aiming to personalise radiotherapy management.
 

 CVName
View CVDPD NIHR Biography.doc
















<< Search SI Directory